Volker Hitzel

This inventor holds 21 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Hoechst Aktiengesellschaft, Boehringer Mannheim Gmbh. Active years: 1976-1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Volker Hitzel. Retrieved from https://idiyas.com/inventor/volker-hitzel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 21

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 8

Forward Citations = 234(Granted Patents)

Location History:

Lorsbach, Taunus, DE (1976 - 1977)
Hofheim, DE (1979)
Lorsbach, DE (1980 - 1981)
Hofheim am Taunus, DE (1979 - 1986)

Company Filing History:

19 out of 6,705

Hoechst Aktiengesellschaft

patents

2 out of 1,164

Boehringer Mannheim Gmbh

patents

Years Active: 1976-1986

Loading Chart...

Areas of Expertise:

Sulfonylureas

Antidiabetic Compounds

Pharmaceutical Formulations

Heterocyclic Substituted

Benzoic Acid Derivatives

Thienopyrrolone

Piperidine

Nicotinamido

Acylamino

Hypoglycemic Derivatives

Pharmaceutical Preparations

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4585775 - Substituted pyrido (1,2-c)imidazo(1,2-a)benzimidazoles, processes for (1986-04-29),

2. 4542139 - Sulfonylureas pharmaceutical formulations based on these compounds and (1985-09-17),

3. 4542127 - Antidiabetic salicylic acid derivatives (1985-09-17),

4. 4379785 - Heterocyclic substituted sulfonyl ureas, and their use (1983-04-12),

5. 4379153 - Benzenesulfonyl ureas, and pharmaceutical preparations (1983-04-05),

6. 4325963 - Thienopyrrolone substituted benezenesulfonylureas and their use (1982-04-20),

7. 4315940 - Antidiabetic 1-piperidine-sulfonylureas (1982-02-16),

8. 4282239 - Sulfonyl ureas and pharmaceutical preparations thereof (1981-08-04),

9. 4278680 - Hypoglycaemically and hypolipidaemically active derivatives of (1981-07-14),

10. 4221815 - Benzoic acids, their derivatives and process for preparing them (1980-09-09),

11. 4207341 - Hypoglycaemically and hypolipidaemically active derivatives of (1980-06-10),

12. 4182775 - Benzoic acids and process for their preparation (1980-01-08),

13. 4181658 - Certain nicotinamido-n-benzoic acid derivatives (1980-01-01),

14. 4158063 - Acylamino(alkyl)benzene derivatives and process for preparing them (1979-06-12),

15. 4157395 - Benzenesulfonyl ureas (1979-06-05),

Title: Volker Hitzel: Innovator in Pharmaceutical Chemistry

Introduction

Volker Hitzel, based in Hofheim am Taunus, Germany, is a notable inventor in the field of pharmaceutical chemistry. With an impressive portfolio of 21 patents, he has made significant contributions to the development of innovative compounds and processes that have vital implications in medicinal applications.

Latest Patents

Among his latest patents, one notable invention is related to substituted pyrido(1,2-c)imidazo(1,2-a)benzimidazoles. This invention includes compounds characterized by specific molecular formulas, where various groups like R¹ and R² can represent hydrogen, alkyl, trifluoromethyl, and other substituents. These compounds are particularly valued for their role as gastric acid secretion inhibitors and their development into pharmaceutical preparations.

Another significant contribution from Hitzel includes sulfonylureas, with claims covering formulations that incorporate various alkyl groups, cycloalkyls, and physiologically acceptable salts. These compounds are further processed into medicaments, showcasing Hitzel's commitment to enhancing therapeutic options.

Career Highlights

Volker Hitzel has held key positions in prominent companies such as Hoechst Aktiengesellschaft and Boehringer Mannheim GmbH. His tenure at these esteemed organizations has played a crucial role in shaping his expertise in pharmaceutical innovations, allowing him to lead projects that resulted in multiple patents and advancements in drug formulations.

Collaborations

Throughout his career, Hitzel has collaborated with distinguished professionals like Rudi Weyer and Karl Geisen. Their joint efforts have facilitated a dynamic exchange of ideas and expertise, contributing to the successful development of novel pharmaceutical compounds and processes.

Conclusion

With 21 patents to his name, Volker Hitzel stands out as an influential figure in pharmaceutical innovation. His recent work on compounds for pharmaceutical formulations highlights his dedication to advancing medicine and improving patient care. Through his collaborations and career achievements, Hitzel continues to impact the field significantly, paving the way for future innovations.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]